References
-
1
Wildi S M, Glenn T F, Woolson R F. et al .
Is esophagoscopy alone sufficient for patients with reflux symptoms. Final results [abstract]?.
Gastrointest Endosc.
2004;
59
AB261
-
2
Dy F T, Sollano J D, Jr, Quino A P. et al .
Lugol’s chromoendoscopy improves the detection of esophagitis in patients with nonerosive reflux disease [abstract].
Gastrointest Endosc.
2004;
59
AB243
-
3
Achem S R, Stark M E, Ferguson D D. et al .
Extended (48-hr) monitoring in patients with extra-esophageal manifestations of GERD [abstract].
Gastrointest Endosc.
2004;
59
AB246
-
4
Martinez S D, Malagon I B, Garewal H S. et al .
Non-erosive reflux disease (NERD): acid reflux and symptom patterns.
Aliment Pharmacol Ther.
2003;
17
537-545
-
5
Martinek J, Benes M, Hucl T. et al .
How do endoscopy positive and endoscopy negative gastroesophageal reflux diseases differ? Prospective evaluation of patients with gastroesophageal reflux disease (GERD) [abstract].
Gastroenterology.
2004;
126
A496
-
6
Rothstein R I, Hynes M L, Grove M R. et al .
Endoscopic gastric plication (EndoCinch) for GERD: a randomized, sham-controlled, blinded, single-center study [abstract].
Gastrointest Endosc.
2004;
59
AB111
-
7
Ponchon T, Boyer J, Grimaud J C. et al .
A prospective multicenter phase II study to evaluate EndoCinch suturing system for the treatment of GERD [abstract].
Gastrointest Endosc.
2004;
59
AB244
-
8
Zabel-Langhennig A, Schiefke I, Neumann S. et al .
Endoscopic gastroplication (EndoCinch) as alternative option in treatment of GERD: an 18-month follow-up [abstract].
Gastroenterology.
2004;
126
A-330
-
9
Liu J J, Saltzman J, Ookubo R. et al .
Predictors of long-term success of endoscopic treatment for gastroesophageal reflux disease [abstract].
Gastroenterology.
2004;
126
A331
-
10
Davis R, Gerhardt J, Welch R. et al .
Comparison of endoluminal gastroplication configuration techniques: a long-term study [abstract].
Gastrointest Endosc.
2004;
59
AB245
-
11
Miller L S, Dai Q, Dimitriou J. et al .
Endoscopic plication (EndoCinch) repairs a physiologic defect in patients with gastroesophageal reflux disease (GERD): absent pressure profile due to the gastric sling fibers [abstract].
Gastroenterology.
2004;
126
A330
-
12
Saeed Z A, Khan A A, Alam A. et al .
Does the number of sutures make a difference. A study with a new device for endoluminal treatment of gastroesophageal reflux [abstract]?.
Gastrointest Endosc.
2004;
59
AB151
-
13
Liu J J, Ookubo R, Saltzman J.
The clinical efficacy of the endoscopic suturing device for treatment of gastroesophageal reflux disease [abstract].
Gastrointest Endosc.
2004;
59
AB245
-
14
Noar M, Smith J.
The Stretta procedure improves GERD symptoms and anti-secretory drug use at 2 years, while normalizing gastric emptying function in the majority of impaired subjects [abstract].
Gastrointest Endosc.
2004;
59
AB244
-
15
Haringsma J, Masclee A AM, de Jong C. et al .
Effect of radiofrequency energy therapy on reflux mechanisms and vagus nerve function in patients with GERD [abstract].
Gastroenterology.
2004;
126
A330
-
16
McClusky D A, Khaitan L, Swafford V A. et al .
Radiofrequency energy delivery to the lower esophageal sphincter in patients with recurrent reflux after antireflux surgery: can redo surgery be avoided. [abstract]?.
Gastroenterology.
2004;
126
A798
-
17
Devière J, Cohen L B, Aisenberg J. et al .
Predictors of Enteryx outcomes at 12 months [abstract].
Gastrointest Endosc.
2004;
59
AB243
-
18
Lehman G A, Hieston K, Cohen L B. et al .
Correlation between clinical outcome and Enteryx implant shape [abstract].
Gastrointest Endosc.
2004;
59
AB149
-
19
Johnson D A, Aisenberg J, Cohen L B. et al .
Clinical benefits of Enteryx for high-dose PPI patients [abstract].
Gastrointest Endosc.
2004;
59
AB245
-
20
Fockens P, Boeckxstaens G, Gabbrielli A. et al .
Endoscopic augmentation of the lower esophageal sphincter for GERD: final results of a European multicenter study of the Gatekeeper System [abstract].
Gastrointest Endosc.
2004;
59
AB242
-
21
Gabbrielli A, Cipolloni L, Pandolfi M. et al .
Gatekeeper™ reflux repair system: results of two years’ follow-up [abstract].
Gastrointest Endosc.
2004;
59
AB244
-
22
Pleskow D, Rothstein R, Lo S. et al .
Endoscopic full-thickness plication for GERD: durability at 12 months [abstract].
Gastrointest Endosc.
2004;
59
AB243
-
23
Ganz R A, Rydell M, Termin P.
Accurate localization of Enteryx into the deep esophageal wall without fluoroscopy [abstract].
Gastrointest Endosc.
2004;
59
AB242
-
24
Fockens P, Bruno M J, Gabbrielli A. et al .
Endoscopic augmentation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease: multicenter study of the Gatekeeper™ Reflux Repair System.
Endoscopy.
2004;
[in press]
-
25
Edmundowicz S A, Perrone J M, Siegel L C. et al .
Randomized controlled evaluation of a novel endoscopic stapling system in an animal model for GERD [abstract].
Gastrointest Endosc.
2004;
59
AB148
-
26
Vinciane M.
A prospective endoscopic study of cardial intestinal metaplasia [abstract].
Gastrointest Endosc.
2004;
59
AB258
-
27
Gerson L B, Shetler K, Triadafilopoulos G.
Prevalence of Barrett’s esophagus in asymptomatic individuals.
Gastroenterology.
2002;
123
461-467
-
28
Dulai G, Jensen D M, Saad M. et al .
Simultaneous screening for Barrett’s and colorectal cancer [abstract].
Gastrointest Endosc.
2004;
59
AB259
-
29
DeVault K R, Ward E M, Wolfsen H C. et al .
Barrett’s esophagus (BE) is common in older patients undergoing screening colonoscopy regardless of gastroesophageal reflux (GER) symptoms [abstract].
Gastrointest Endosc.
2004;
59
AB111
-
30
Siersema P D, Yu S, Sahbaie P. et al .
Colorectal neoplasia in veterans is associated with Barrett’s esophagus but not with use of proton-pump inhibitors (PPIs) or aspirin/NSAIDs [abstract].
Gastrointest Endosc.
2004;
59
AB259
-
31
Wong S N, Sollano J D, Jr, Chan M M. et al .
Unrecognized Barrett’s esophagus in patients with erosive esophagitis unveiled by methylene blue chromoendoscopy [abstract].
Gastrointest Endosc.
2004;
59
AB262
-
32
Kim H K, Park S H, Kim J K. et al .
Acetic acid chromoendoscopy improved detection of islands of Barrett’s epithelium in GERD patients [abstract].
Gastrointest Endosc.
2004;
59
AB264
-
33
Hanna S, Weston A, Mathur S. et al .
The detection of Barrett’s esophagus after endoscopic healing of erosive esophagitis [abstract].
Gastrointest Endosc.
2004;
59
AB261
-
34
Ferguson D D, DeVault K R, Wolfsen H C.
Should we biopsy an irregular Z-line? The yield of biopsy to diagnose short-segment Barrett’s esophagus [abstract].
Gastrointest Endosc.
2004;
59
AB264
-
35
Sharpe L M, Li X, Cowan D. et al .
Temporal change in Barrett’s esophagus segment length (BESL) during prospective surveillance [abstract].
Gastrointest Endosc.
2004;
59
AB262
-
36
Gatenby P AC, Caygill C PJ, Ramus J R. et al .
Does the length of the columnar-lined esophagus (CLO) change with time? [abstract].
Gastroenterology.
2004;
126
A177
-
37
Kara M, Ennahachi M, Fockens P. et al .
Narrow-band imaging (NBI) in Barrett’s esophagus (BE): what features are relevant for the detection of high-grade dysplasia (HGD) and early cancer (EC)? [abstract].
Gastroenterology.
2004;
126
A50
-
38
Sharma P, Mathur S, Dixon A. et al .
Narrow-band imaging endoscopy for the detection of dysplastic and nondysplastic Barrett’s esophagus [abstract].
Gastrointest Endosc.
2004;
59
AB263
-
39
Miros M, Cohn D, Walker N.
Acetic acid magnification chromoendoscopy detects all focal high-grade dysplasia in Barrett’s esophagus [abstract].
Gastrointest Endosc.
2004;
59
AB264
-
40
Lovat L B, Johnson K, Novelli M R. et al .
Optical biopsy using elastic scattering spectroscopy can detect high-grade dysplasia and cancer in Barrett’s esophagus [abstract].
Gastroenterology.
2004;
126
A22
-
41
Rabago L R, Delgado M, de Vicente C. et al .
Intraoperative ERCP for the management of choledocholithiasis: a comparative study [abstract].
Gastrointest Endosc.
2004;
59
AB199
-
42
Evans J A, Poneros J M, Bouma B R. et al .
Application of a histopathologic scoring system to optical coherence tomography (OCT) images to identify high-grade dysplasia in Barrett’s esophagus [abstract].
Gastroenterology.
2004;
126
A51
-
43
Kara M, DaCosta R, Streutker C. et al .
Characterization of tissue autofluorescence (AF) in non-dysplastic (NDBE) and dysplastic Barrett’s esophagus (BE) by confocal fluorescence microscopy [abstract].
Gastroenterology.
2004;
126
A50-51
-
44
Gossner L, May A, Stolte M. et al .
High-resolution chromoendoscopy with acetic acid for the detection of intestinal metaplasia and early neoplasia in Barrett’s esophagus [abstract].
Gastrointest Endosc.
2004;
59
AB261
-
45
Lightdale C, Larghi A, Rotterdam H. et al .
Endoscopic ultrasonography (EUS) and endoscopic mucosal resection (EMR) for staging and treatment of high-grade dysplasia (HGD) and early adenocarcinoma (EAC) in Barrett’s esophagus (BE) [abstract].
Gastrointest Endosc.
2004;
59
AB90
-
46
Gatenby P AC, Ramus J R, Caygill C PJ. et al .
Incidence of adenocarcinoma in short- and long-segment columnar-lined esophagus [abstract].
Gastroenterology.
2004;
126
A308
-
47
Von Rahden B HA, Stein H J, Feith M. et al .
Experiences with endoscopic surveillance of patients with Barrett’s esophagus in a single German center [abstract].
Gastroenterology.
2004;
126
A795
-
48
Misra N, Roberts L, Hardwick R H.
Is improved accuracy of reporting an explanation for the increasing incidence of junctional adenocarcinoma? [abstract].
Gastroenterology.
2004;
126
A308
-
49
Lewis J, Lutzke L, Smyrk T. et al .
The limitations of endoscopic mucosal resection in Barrett’s esophagus [abstract].
Gastrointest Endosc.
2004;
59
AB101
-
50
Conio M, Repici A, Cestari R. et al .
Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma occurring in Barrett’s esophagus [abstract].
Gastrointest Endosc.
2004;
59
AB253
-
51
Vieth M, Ell C, Gossner L. et al .
Histologic analysis of endoscopic resection specimens from patients with Barrett’s esophagus and early neoplasia.
Endoscopy.
2004;
36
690-695
-
52
Saito Y, Matsuda T, Saito D. et al .
Does endoscopic resection increase the risk of lymph-node metastases? [abstract].
Gastrointest Endosc.
2004;
59
AB274
-
53
Seewald S, Groth S, Brand B. et al .
Circumferential EMT: future endoscopic management of HGIN and IMC in Barrett’s esophagus? Preliminary results of an ongoing study [abstract].
Gastrointest Endosc.
2004;
59
AB101
-
54
Urayama S, Umphress J L.
Wide endoscopic mucosal resection in esophagus using modified needle-knife: porcine model experiment [abstract].
Gastrointest Endosc.
2004;
59
AB258
-
55
Dye C, Kinney T, Chi K. et al .
Holmium laser-assisted mucosectomy (HLAM) [abstract].
Gastrointest Endosc.
2004;
59
AB90
-
56
De la Mora J G, Rajan E, Gostout C J. et al .
Intramural endoscopic dissection using pressurized gas: a novel approach to large-area mucosal resection [abstract].
Gastrointest Endosc.
2004;
59
AB91
-
57
Raju G S, Ahmed I, Xiao S Y. et al .
Graded esophageal mucosal ablation with cryotherapy and protective effects of submucosal saline [abstract].
Gastrointest Endosc.
2004;
59
AB150
-
58
Sharma V K, Fleischer D E, Wang K K. et al .
A randomized multicenter trial of radiofrequency (RF) ablation of specialized intestinal metaplasia (SIM) of the esophagus using a balloon-based bipolar electrode array: preliminary results [abstract].
Gastrointest Endosc.
2004;
59
AB113
-
59
Kelty C J, Ackroyd R, Brown N J. et al .
Endoscopic ablation of Barrett’s esophagus: a randomized trial of photodynamic therapy (PTD) versus argon plasma coagulation (APC) [abstract].
Gastrointest Endosc.
2004;
59
AB250
-
60
Forcione D G, Hasan T, Ortel B J. et al .
Optimization of aminolevulinic acid-based photodynamic therapy of Barrett’s esophagus with high-grade dysplasia [abstract].
Gastrointest Endosc.
2004;
59
AB251
-
61
Selvasekar C R, Novelli M R, Thorpe S. et al .
Interim results of a randomized controlled trial (RCT) comparing green and red laser photodynamic therapy using low-dose ALA for high-grade dysplasia in Barrett’s esophagus [abstract].
Gastrointest Endosc.
2004;
59
AB252
-
62
Rahmani E Y, Nehme O, Arney K. et al .
Successful eradication of Barrett’s mucosa with argon coagulation and acid suppression: mid-term results [abstract].
Gastrointest Endosc.
2004;
59
AB250
-
63
Rahmani E Y, Turpin C, Arney K.
Photodynamic therapy for dysplastic Barrett’s esophagus and early esophageal adenocarcinoma should be first-line therapy [abstract].
Gastrointest Endosc.
2004;
59
AB250
-
64
Wolfsen H C, Hemminger L L.
Photodynamic therapy for dysplastic Barrett’s esophagus and mucosal adenocarcinoma [abstract].
Gastrointest Endosc.
2004;
59
AB251
-
65
Wang K K, Song L MWK, Buttar N. et al .
Barrett’s esophagus after photodynamic therapy: risk of cancer development during long-term follow-up [abstract].
Gastroenterology.
2004;
126
A50
-
66
Peters F, Kara M, Rosmolen W. et al .
Endoscopic resection combined with photodynamic therapy for high-grade dysplasia and early cancer in Barrett’s esophagus [abstract].
Gastrointest Endosc.
2004;
59
AB251
-
67
Haringsma J, Siersema P D, Kuipers E J.
Endoscopic ablation of Barrett’s neoplasia: Rotterdam results [abstract].
Gastrointest Endosc.
2004;
59
AB252
-
68
Ganz R A, Utley D S, Stern R. et al .
Complete ablation of porcine esophageal epithelium using a balloon-based bipolar electrode [abstract].
Gastrointest Endosc.
2004;
59
AB250
-
69
Ganz R A, Batts K.
Pilot human study of a balloon-based bipolar electrode for ablation of esophageal epithelium: results in subjects prior to planned esophagectomy [abstract].
Gastrointest Endosc.
2004;
59
AB252
T. Rösch
Charité · Universitätsmedizin Berlin · Campus Virchow Klinikum · Medizinische Klinik m.S. Hepatologie und Gastroenterologie · Zentrale Interdisciplinäre Endoskopie
Augustenburger Platz 1 · 13535 Berlin · Germany
Fax: +49-30-450-553902
Email: thomas.roesch@charite.de
